QUEST DIAGNOSTICS INC — Board/Management Information 2012

Feb 29, 2012

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

Field: Rule-Page

Field: /Rule-Page

FORM 8-K/A

---

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report ( Date of Earliest Event Reported ) : December 6, 2011

---

Quest Diagnostics Incorporated

(Exact Name of Registrant as Specified in Its Charter)

---

Delaware

(State or other jurisdiction of Incorporation)

001-12215	16-1387862
(Commission File Number)	(I.R.S. Employer Identification No.)
Three Giralda Farms Madison, NJ 07940	07940
(Address of principal executive offices)	(Zip Code)
(973) 520-2700
(Registrant’s telephone number, including area code )

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction a.2. below):

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))

Field: Rule-Page

Field: /Rule-Page

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 6, 2011, Quest Diagnostics Incorporated (the “Company”) filed a Current Report on Form 8-K (the “Initial Filing”) announcing the appointment of Mr. Timothy M. Ring to the Board of Directors (“Board”). At the time of the Initial Filing, it had not been determined to which committees of the Board Mr. Ring would be named. The Company hereby amends the Initial Filing to report that effective February 26, 2012, Mr. Ring was appointed to the Compensation Committee of the Board and the Quality, Safety and Compliance Committee of the Board.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

February 29, 2012
QUEST DIAGNOSTICS INCORPORATED
By:	/s/ William J. O’Shaughnessy, Jr.
	William J. O’Shaughnessy, Jr.
	Assistant General Counsel and
	Secretary